Immunoregulation by liposomal model membrane
Yasuda, T.
Seikagaku. Journal of Japanese Biochemical Society 54(5): 311-314
1982
ISSN/ISBN: 0037-1017 PMID: 7130761 Document Number: 191576
Document emailed within 1 workday
Related Documents
Tadakuma, T.; Yasuda, T. 1981: Analysis of the mechanism of B cell activation by using hapten-sensitized liposomal model membranes Nihon Saikingaku Zasshi. Japanese Journal of Bacteriology 36(6): 719-724Pan, X.Q.; Lee, R.J. 2005: In vivo antitumor activity of folate receptor-targeted liposomal daunorubicin in a murine leukemia model Anticancer Research 25(1a): 343-346
Sahm, M.; Wingen, F.; Hager, J.; Seitz, H.M. 1996: Enhanced efficacy of a liposomal pentamidine preparation in Pneumocystis carinii in an ex vivo/in vitro culture model without feederlayer cells Applied Parasitology 37(2): 137-145
Iwaszkiewicz, K.S.; Hua, S. 2014: Development of an effective topical liposomal formulation for localized analgesia and anti-inflammatory actions in the Complete Freund's Adjuvant rodent model of acute inflammatory pain Pain Physician 17(6): E719-E735
Garoff, H. 1978: Virus envelope as an membrane model Duodecim; Laaketieteellinen Aikakauskirja 94(20): 1270-1277
Doonan, B. 1977: Membrane fluidity gradient model of cell transport Physiological Chemistry and Physics 9(2): 189-201
Rubin, H. 2005: The membrane, magnesium, mitosis (MMM) model of cell proliferation control Magnesium Research 18(4): 268-274
Wendel, I.; Behlke, J.; Jänig, G.R. 1983: Determination of the partial specific volume of cytochrome P-450 as a model of a membrane protein Biomedica Biochimica Acta 42(6): 623-631
Brandys, J.; Kwiek, J.; Witek, J. 1974: An in vitro collodion-lipid membrane model for drug absorption studies Polish Journal of Pharmacology and Pharmacy 26(5): 519-526
Resh, M.D. 1990: Membrane interactions of pp60v-src: a model for myristylated tyrosine protein kinases Oncogene 5(10): 1437-1444
McGillis, J.P.; Organist, M.L.; Payan, D.G. 1987: Substance P and immunoregulation Federation Proceedings 46(1): 196-199
Köhidai, L.; Muto, Y.; Nozawa, Y.; Csaba, G. 1986: Studies on the interrelationship between hormonal imprinting and membrane potential in model experiments on Tetrahymena Cellular and Molecular Biology 32(6): 641-645
Markley, K. 1979: Burned patients and immunoregulation Journal of Trauma 19(11 Suppl): 891-892
Mozes, E.; Mendlovic, S.; Kalush, F.; Waisman, A.; Shoenfeld, Y.; Fricke, H. 1990: Immunoregulation of autoimmune diseases Israel Journal of Medical Sciences 26(12): 688-690
Lefrak, E.A.; Stevens, P.M.; Nicotra, M.B.; Viroslav, J.; Noon, G.P.; DeBakey, M.E. 1973: An experimental model for evaluating extracorporeal membrane oxygenator support in acute respiratory failure American Surgeon 39(1): 20-30
Gorbenko, G.P. 1999: Changes in the model membrane structure induced by ribonuclease and lysozyme studied by the fluorescent probe technique Biofizika 44(6): 1048-1053
Datta, C.; Gupta, M.R. 1977: Kinetic model of biphasic action of psychotropic drugs on membrane-bound enzyme systems Indian Journal of Experimental Biology 15(1): 58-60
Germuth, F.G.; Rodriguez, E.; Shah, H.J.; Lorelle, K.; McGee, S.; Milano, L.; Wise, O. 1978: Antibasement membrane disease. II. Mechanism of glomerular injury in an accelerated model of Masugi nephritis Laboratory Investigation; a Journal of Technical Methods and Pathology 39(5): 421-429
Ozdemir, N.; Ozalp, Y.; Ozkan, Y. 2000: Effects of membrane composition on release of model hydrophilic compound from osmotic delivery systems Acta Poloniae Pharmaceutica 57(3): 181-186
Peng, J.; Lapolla, S.M.; Zhang, Z.; Lin, J. 2009: The cytosolic domain of Bcl-2 oligomerizes to form pores in model mitochondrial outer membrane at acidic pH Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 26(3): 631-637